PORTAGE BIOTECH INC. Quarterly Liabilities in USD from Q1 2017 to Q1 2024

Taxonomy & unit
ifrs-full: USD
Summary
Portage Biotech Inc. quarterly Liabilities history and growth rate from Q1 2017 to Q1 2024.
  • Portage Biotech Inc. Liabilities for the quarter ending March 31, 2024 was $4.45M, a 81.3% decline year-over-year.
Liabilities, Quarterly (USD)
Liabilities, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 $4.45M -$19.3M -81.3% Mar 31, 2024 20-F 2024-08-14
Q4 2023 $17.7M -$24.7M -58.2% Dec 31, 2023 6-K 2024-02-28
Q3 2023 $25.4M -$13.3M -34.4% Sep 30, 2023 6-K 2023-11-28
Q2 2023 $25.7M -$12.2M -32.2% Jun 30, 2023 6-K 2023-08-29
Q1 2023 $23.7M -$5.49M -18.8% Mar 31, 2023 20-F 2024-08-14
Q4 2022 $42.4M +$18.1M +74.8% Dec 31, 2022 6-K 2023-03-01
Q3 2022 $38.7M +$13.9M +55.8% Sep 30, 2022 6-K 2022-11-29
Q2 2022 $37.9M +$11.3M +42.2% Jun 30, 2022 6-K/A 2022-10-13
Q1 2022 $29.2M +$1.97M +7.23% Mar 31, 2022 20-F 2023-07-31
Q4 2021 $24.2M Dec 31, 2021 6-K 2022-02-25
Q3 2021 $24.9M Sep 30, 2021 6-K 2021-11-23
Q2 2021 $26.7M Jun 30, 2021 6-K 2021-08-30
Q1 2021 $27.3M -$275K -1% Mar 31, 2021 20-F 2022-08-01
Q1 2020 $27.5M +$2.38M +9.44% Mar 31, 2020 20-F/A 2022-03-04
Q1 2019 $25.2M +$24.8M +6452% Mar 31, 2019 20-F 2020-08-18
Q1 2018 $384K +$74K +23.9% Mar 31, 2018 20-F 2019-12-30
Q1 2017 $310K Mar 31, 2017 20-F 2018-07-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.